Progression, dosage, and clinical aspects of the treatment.
|Progression||Dosage (average)||Wound size||Clinical aspects|
|1st week||7 g||6,5 cm||The patient took Gabapentin 300 mg qid and Oxycodone 15 mg bid; from the second session he reported a reduction of phantom limb pain|
|2nd week||18 g||3,5 cm||The patient temporally stopped oral therapy; he referred to a feeling of wellness|
|3rd week||24 g||2,5 cm (at the 1st session of the week), 1,9 cm (at the end of the week)||Good control of the pain; oral therapy only when needed (600 mg Gabapentin/die + 5 mg Oxycodone/die)|
|4th week||14 g||1 cm||No more phantom limb pain, no nausea|
|5th week||6 g||Closed (at the 5th day of the week)||Good control of the pain, feeling of wellness|